Update on the Regulation of LDTs: FDA, VALID Act, CLIA Modernization, and More 

Members of the American College of Medical Genetics and Genomics' Advocacy and Government Affairs Committee and Policy Team provide updates on potential changes to the regulation of laboratory-developed tests (LDTs) in the US. Speakers provide updates on the current status of the FDA’s rule on regulation of LDTs and its implementation. They also provide updates on congressional involvement, including legislative efforts such as the VALID Act and CLIA Modernization.
Speakers include:
Michelle McClure, PhD - ACMG Director of Public Policy
Marco Leung, PhD, FACMG - ACMG Advocacy & Govt Affairs Committee Chair
Sarah South, PhD, FACMG - ACMG Board of Directors